Brief: Sk Bioscience Receives Approval For Skycovion Covid-19 Vaccine From Uk’S Mhra
30/05/2023 03:43
May 30 (Reuters) - SK Bioscience Co Ltd 302440.KS :
* SK BIOSCIENCE: RECEIVES APPROVAL FOR SKYCOVION COVID-19
VACCINE
FROM UK’S MHRA
Source text for Eikon: ID:
Further company coverage: 302440.KS
Recent news on SK bioscience
See all newsBrief: Sk Bioscience Co Wins 23.9 Billion Won Order
Brief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate